Insider Transactions in Q4 2024 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 14
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,293
-1.86%
|
$197,478
$46.28 P/Share
|
|
Oct 14
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,089
-1.71%
|
$50,094
$46.28 P/Share
|
|
Oct 13
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+3.48%
|
-
|
|
Oct 13
2024
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,113
+3.21%
|
-
|